Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Dec 2024 04:49 PM
RNS
TR-1
09 Dec 2024 07:00 AM
RNS
Wanda Health Fundraising
05 Dec 2024 07:00 AM
RNS
Close of Fundraising and Result of Retail Offer
03 Dec 2024 01:24 PM
RNS
Result of Subscription
03 Dec 2024 07:05 AM
RNS
WRAP Retail Offer
03 Dec 2024 07:00 AM
RNS
Proposed Subscription and Retail Offer; Update
14 Nov 2024 03:59 PM
RNS
Replacement RNS: PDS: Update, 3rd Quarter Results
14 Nov 2024 03:23 PM
RNS
PDS: Clinical Programs Update, 3rd Quarter Results
08 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
03 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
02 Oct 2024 04:38 PM
RNS
PDS: 36-Month Overall Survival Rate announcement
30 Sep 2024 07:00 AM
RNS
Interim Results
26 Sep 2024 07:00 AM
RNS
Name change and AIM Rule 26 website
16 Sep 2024 02:31 PM
RNS
PDS: Updated Results, VERSATILE-002 Phase 2 Trial
13 Aug 2024 03:57 PM
RNS
PDS Biotech: Business Update and Q2 2024 Results
02 Aug 2024 12:21 PM
RNS
Replacement RNS: PDS Biotech Aligns with FDA
02 Aug 2024 07:00 AM
RNS
PDS Biotech Aligns with FDA on Phase 3 Trial
30 Jul 2024 07:00 AM
RNS
Q-Bot Fundraising
10 Jul 2024 10:48 AM
RNS
Result of AGM
18 Jun 2024 07:00 AM
RNS
Notice of AGM
14 Jun 2024 02:10 PM
RNS
TR-1
14 Jun 2024 07:00 AM
RNS
Director/PDMR Shareholding
13 Jun 2024 07:00 AM
RNS
Preliminary Results for the year ended 31 Dec 2023
31 May 2024 07:01 AM
RNS
Notice of Results and Investor Presentation
31 May 2024 07:00 AM
RNS
DeepTech Recycling: Fundraising, Business Update
28 May 2024 07:00 AM
RNS
Investment in Wanda, related party transactions
15 May 2024 02:32 PM
RNS
PDS Biotech: Business Update and Q1 2024 Results
13 May 2024 07:00 AM
RNS
Martlet Capital: mandate and acquisition
10 May 2024 09:12 AM
RNS
PDS Biotech: Clinical trial meets study endpoints
15 Apr 2024 07:00 AM
RNS
ProAxsis secures c.£1.8mn investment
27 Mar 2024 01:34 PM
RNS
PDS Strategy Update and 2023 Financial Results
13 Mar 2024 07:00 AM
RNS
Business Update
05 Feb 2024 07:00 AM
RNS
Exercise of Options and Issue of Shares
23 Jan 2024 07:00 AM
RNS
Glycotest secures $1 million investment
01 Dec 2023 07:00 AM
RNS
DeepTech Recycling secures £1 million investment
14 Nov 2023 04:39 PM
RNS
PDS BioTechnology: Third Quarter Results
13 Nov 2023 07:00 AM
RNS
Director/PDMR Shareholding
09 Nov 2023 05:28 PM
RNS
PDS Biotech Announces Updated Survival Data
06 Nov 2023 07:00 AM
RNS
Ventive secures c.£900,000 investment
02 Nov 2023 07:00 AM
RNS
Change of Adviser
23 Oct 2023 06:22 PM
RNS
PDS Preliminary Biomarker Study Results
13 Oct 2023 07:00 AM
RNS
Exercise of Options
03 Oct 2023 04:12 PM
RNS
Director/PDMR Shareholding
03 Oct 2023 03:21 PM
RNS
PDS: Interim 24-month survival rate of 74% update
03 Oct 2023 07:00 AM
RNS
PDS Biotech: new data on PDS0101
28 Sep 2023 07:00 AM
RNS
Interim Results
13 Sep 2023 07:00 AM
RNS
Q-Bot: £3.5 million investment to drive expansion
14 Aug 2023 05:55 PM
RNS
PDS Biotech: 2nd Quarter Results, Business Update
14 Aug 2023 05:51 PM
RNS
PDS Biotech: Submission of Phase 3 Protocol to FDA
03 Jul 2023 07:00 AM
RNS
Grant of Options, Issue of Shares, Director/PDMR
UK 100

Latest directors dealings